Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Methods (San Diego, Calif.)|July 4, 2014
A high-content assay for identifying small molecules that reprogram C. elegans germ cell fateJoshua A Benson, Erin E Cummings, Linda P O'Reilly, et al.Expert Opinion on Drug Discovery|July 8, 2014
Worming our way to novel drug discovery with the Caenorhabditis elegans proteostasis network, stress response and insulin-signaling pathwaysLinda P O'Reilly, Joshua A Benson, Erin E Cummings, et al.Plos One|February 6, 2014
Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiencyJie Li, Stephen C Pak, Linda P O'Reilly, et al.Human Molecular Genetics|May 20, 2014
A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiencyLinda P O'Reilly, Olivia S Long, Murat C Cobanoglu, et al.Human Molecular Genetics|May 20, 2014
A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnoverOlivia S Long, Joshua A Benson, Joon Hyeok Kwak, et al.Pageof 1